These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Biotechnology products: new opportunities and responsibilities for the pharmacist. Stewart CF; Fleming RA Am J Hosp Pharm; 1989 Nov; 46(11 Suppl 2):S4-8. PubMed ID: 2603870 [TBL] [Abstract][Full Text] [Related]
3. Reimbursement and pharmacoeconomic perspectives in biotechnology. Bleecker GC Am J Hosp Pharm; 1993 Jul; 50(7 Suppl 3):S27-30. PubMed ID: 8362887 [TBL] [Abstract][Full Text] [Related]
4. Managing high cost and biotech drugs: two institutions' perspectives. Dana WJ; McWhinney B Hosp Formul; 1994 Sep; 29(9):638-45. PubMed ID: 10137060 [TBL] [Abstract][Full Text] [Related]
5. Research and development of drugs and biologic entities. Piascik MM Am J Hosp Pharm; 1991 Oct; 48(10 Suppl 1):S4-13. PubMed ID: 1772113 [TBL] [Abstract][Full Text] [Related]
6. The pharmacoeconomics of high-cost biotechnology products. Dana WJ; Farthing K Pharm Pract Manag Q; 1998 Jul; 18(2):23-31. PubMed ID: 10185236 [TBL] [Abstract][Full Text] [Related]
7. Strategic planning for clinical services: panel discussion. Pierpaoli PG; Anderson RW; Kelly WN; Linggi A; Pelham LD Am J Hosp Pharm; 1986 Sep; 43(9):2174-7. PubMed ID: 3532779 [TBL] [Abstract][Full Text] [Related]
8. Integrating human resources and program-planning strategies. Smith JE Am J Hosp Pharm; 1989 Jun; 46(6):1153-61. PubMed ID: 2665482 [TBL] [Abstract][Full Text] [Related]
9. Harvey A. K. Whitney lecture. Interdependence in pharmacy: risks, rewards, and responsibilities. Zilz DA Am J Hosp Pharm; 1990 Aug; 47(8):1759-65. PubMed ID: 2389781 [TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical care in community pharmacies: practice and research in Peru. Alvarez-Risco A; van Mil JW Ann Pharmacother; 2007 Dec; 41(12):2032-7. PubMed ID: 17940126 [TBL] [Abstract][Full Text] [Related]
15. Biotechnology: an overview of the tools, therapeutic agents, and applications to pharmacy practice. Piascik P Pharm Pract Manag Q; 1998 Jul; 18(2):1-12. PubMed ID: 10185234 [TBL] [Abstract][Full Text] [Related]
16. Factors that influence prescribing decisions. Schumock GT; Walton SM; Park HY; Nutescu EA; Blackburn JC; Finley JM; Lewis RK Ann Pharmacother; 2004 Apr; 38(4):557-62. PubMed ID: 14966259 [TBL] [Abstract][Full Text] [Related]
17. How a collaborative task force can assist in managing biotechnology products. MacKinnon GE Hosp Formul; 1994 Jul; 29(7):526-30, 533. PubMed ID: 10135146 [TBL] [Abstract][Full Text] [Related]
18. Reengineering the retail/ambulatory pharmacy for provision of biotechnology pharmaceutical services. Schneider PJ Pharm Pract Manag Q; 1998 Jul; 18(2):32-6. PubMed ID: 10185237 [TBL] [Abstract][Full Text] [Related]
19. 2006 national clinical pharmacy services survey: clinical pharmacy services, collaborative drug management, medication errors, and pharmacy technology. Bond CA; Raehl CL Pharmacotherapy; 2008 Jan; 28(1):1-13. PubMed ID: 18154468 [TBL] [Abstract][Full Text] [Related]
20. The NCI All Ireland Cancer Conference. Johnston PG; Daly PA; Liu E Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]